Ir al contenido

TrialPal  ePRO & eCOA

TrialPal is our  eCOA (electronic Clinical Outcome Assessment), ePRO (electronic Patient Reported Outcomes) and Site Mobile and web application,used in vaccine clinical trials and decentralized clinical trials. 

Schedule a DEMO

TrialPal Suite


Trialpal Setup

Setup Study Protocols in minutes and prepare Screenshots for IRB Submission in a Day.


Trialpal App

Subject’s easy-to-report, friendly Web, PWA, and Mobile App with offline functionality.

TrialPal Site

The Site’s management console, with reports, eDiary view, eDiary Assessment, and subject follow-up.

Econsent

Interactive Multimedia eConsent enriched with AI.


The Participant´s best friend

TrialPal is an intuitive and easy-to-use tool that monitors clinical trial participants and the study, through dashboards combined with a user-friendly interface created to generate data directly from the trial participants

Download Trialpal Brochure​​​​

Fully Compliant







Dashboards for  
Decision-Making


Study  Dashboard

Our  TrialPal dashboards provide an overview of the trial status. This is accomplished with on-demand indicators such as; symptomatology, intensity per participant by group or site, as well as reports and visit completion.


e-Diary  Dashboard

The dashboards allow detailed tracking of AE and SAE, and other key variables to make data-driven decisions throughout the study. The practical design makes it easier to do analytics and presentations.  

TrialPal  Features

Create any  eDiary and any other trial-specific forms in as little as 1-2 hours as per protocol specifications.

Dual data entry options for participants.

Customized notifications and alerts

With our conciliation module you can review and conciliate easily all the symptoms reported.

This allows users to activate additional modules such as Chat, eConsent, and Telehealth (Beta version), it also provides a way to enable hybrid or Decentralized Clinical Trials (DCT) when integrating TrialPal with Trial360 and EDC.

To enhance interoperability between site  CTMS, EDCs  , or any third-party application.

Reduce implementation and operational costs.  

In TrialPal you can made forms for your surveillance reports using a design mode ; with drag-and-drop features, and all the functionalities you need to create the perfect form for your study needs.  

TrialPal App works in offline mode. The App saves the report on the device, and once it is back online, all the pending data is sent automatically. 

Besides, with the traveler mode , you can go anywhere worldwide and keep reporting the days you are out of your time zone.  

Easily set up vaccine clinical trial eDiary or surveillance forms for symptom monitoring, including: subforms, grading, alerts, and AEs – SAEs real-time notifications to stakeholders, where sites can also act quickly upon receiving subject reports. 

With the Trial Site App , physicians can manage reconciliations, and with Trial API , data is sent automatically to the eCRF or EDC  system.   

Key
Aspects 


Reliable



Configurable ​


Real-time information




User-friendly




Traceability



Works in Mobile and web devices


Success Stories​

We studied the performance of a smartphone application-based participatory syndromic surveillance (PSS) system for collecting syndromic data (acute febrile illness [AFI] and acute gastroenteritis [AGE]) to detect dengue virus (DENV) and norovirus (NoV) on a cohort of children living in a low-resource and rural area of Guatemala.

469 Participants 

207 Households 

322 Participants >68% response rate during the study (April 2015 - June 2016)

Read the article "Performance of a Smartphone Application- Based Participatory Syndromic Surveillance System for Acute Febrile Illness and Acute Gastroenteritis in Rural Guatemala" by D. Olson, Takeda Pharmaceuticals: Consultant, Grant recipient. R. Zambrano, Integra IT: Employee and Shareholder, Salary. S. Rodriguez-Castro, Integra IT: Employee and Shareholder, Salary. E. J. Asturias, Takeda Pharmaceuticals: Consultant and Grant Investigator, Grant recipient, at Oxford Academic.

​FE known by site vs Blood sample collection

​• 77% of samples were collected in the first 2 days.

​• 88% of samples were collected in the window.

Clinical Trial: 935 subjects

​Phase 2 Dengue Vaccine

​Site: Cevaxin Panama

TrialPal 

Study Cases & Resources


TrialPal ePRO/eCOA Offline Functionality: Ensuring Data Continuity in Clinical Research


Read More


TrialPal ePRO/eCOA Dashboards: From Patient Reports to Immediate Action


Read More

Effortless Scalability: How TRIALPAL Supports High-Volume Multicenter Clinical Trials


Read More